Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (8)
  • 2025 (42)
  • 2024 (39)
  • 2023 (25)
  • 2022 (36)
  • 2021 (69)
  • 2020 (49)
  • 2019 (54)
  • 2018 (47)
  • 2017 (38)
  • 2016 (22)
  • 2015 (16)
  • 2014 (22)
  • 2013 (39)
  • 2012 (8)
  • 2011 (32)

Subject

  • Outreach/Drug Prevention (56)
  • Drug Trafficking (48)
  • Take Back Day (47)
  • Fake Pills (32)
  • Prescription Drugs (32)
  • Fentanyl Awareness (31)
  • One Pill Can Kill (25)
  • Public and Media Affairs - also see Congressional Affairs (22)
  • Red Ribbon (21)
  • Overdose (19)
  • Prevention/Education - DEA websites GSAD, JTT etc (17)
  • Synthetic drugs (17)
  • Arrests/Convictions - Major (16)
  • Press Conferences (14)
  • Diversion Division (13)
  • Congressional Affairs (12)
  • Guns/Weapons (12)
  • Major Law Enforcement Operation (12)
  • Pharmaceuticals/Pharmacists/Physicians (11)
  • Seizures (Drugs/Property) (10)
  • Counterfeit Pills (6)
  • Money Laundering (6)
  • Fentanyl Free America (5)
  • Narcoterrorism (5)
  • OCDETF/Task Force (5)
  • Extraditions (4)
  • Gangs (4)
  • Guilty Plea (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Task Forces/Task Force Officers (4)
  • Campaigns (3)
  • Critical Incident (3)
  • HIDTA (3)
  • Other (2)
  • Scam Calls (2)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Recruitment/Office of Training/Graduations (1)

Drug Name

  • Fentanyl (64)
  • Methamphetamine (38)
  • Cocaine (26)
  • Heroin (20)
  • Marijuana (Cannabis) (10)
  • Oxycodone (6)
  • Synthetic Opioids (6)
  • Opioids (5)
  • Marijuana Concentrates (2)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Ketamine (1)
  • Psilocybin (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • San Francisco (847)
  • Miami (840)
  • Seattle (812)
  • St. Louis (808)
  • Atlanta (777)
  • Chicago (629)
  • Washington, DC (617)
  • New Jersey (493)
  • New Orleans (481)
  • Detroit (361)
  • El Paso (350)
  • Dallas (315)
  • Los Angeles (300)
  • Phoenix (274)
  • San Diego (246)
  • Rocky Mountain (166)
  • Philadelphia (140)
  • Louisville (81)
  • Caribe (79)
  • Caribe (1)
  • Sede (414)
  • Omaha (137)
Clear All Results
546 Results - Showing 421 to 430
PRESS RELEASE

DEA Releases 2016 National Heroin Threat Assessment Summary

WASHINGTON - The United States Drug Enforcement (DEA) released the 2016 National Heroin Threat Assessment Summary - (NHTA) today. The report outlines the expanding public health crisis afflicting America due to the use and abuse of heroin and other opioid drugs. Some key facts: The number of people reporting current...
PRESS RELEASE

DEA Collects Record-Setting Amount Of Meds At Latest National Rx Take-Back Day

WASHINGTON - Americans turned in more unused prescription drugs at the most recent DEA National Prescription Drug Take-Back Day than on any of the previous 10 events since it began in 2010, demonstrating their understanding of the value of this service. Last weekend the DEA and over 4,200 of its...
PRESS RELEASE

Top International Drug Money Launderer Arrested In Colombia

WASHINGTON - The United States Drug Enforcement (DEA) today announced the arrest of Nidal Waked, one of the world’s most significant drug money launderers and criminal facilitators. Waked was arrested last Wednesday night in the El Dorado Airport in Bogota by the Colombian National Police, in close coordination with DEA...
PRESS RELEASE

DEA’s National Prescription Drug Take-Back Day Is Saturday

WASHINGTON - After collecting and destroying 5.5 million pounds-2,762 tons-of unused prescription drugs in the past five years, the U.S. Drug Enforcement (DEA) is continuing its efforts to take back unused, unwanted and expired prescription medications. The DEA invites the public to bring their potentially dangerous, unwanted medicines to one...
PRESS RELEASE

DEA Meets With Pharmaceutical Industry Leaders Today To Discuss Collaboratively Preventing Prescription Drug Misuse And Abuse

WASHINGTON - U.S. Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg and the Chief of DEA’s Office of Diversion Control, Lou Milione hosted a meeting today in Washington with industry leaders representing the prescription drug supply chain in America. The purpose of their dialogue was to discuss ways to minimize pharmaceutical...
PRESS RELEASE

DEA Administrator Chuck Rosenberg Statement On Walgreens’ Prescription Drug Take Back Initiative

WASHINGTON - The United States Drug Enforcement (DEA) commends Walgreens for their commitment to install secure collection bins for unused prescription drugs in over 500 of their stores in 40 states. "Take back programs are an important and easy way for the public to anonymously dispose of their unwanted, unused...
PRESS RELEASE

FBI, DEA Release Documentary Film Addressing Heroin/Prescription Drug Abuse

WASHINGTON - In an effort to combat the growing epidemic of prescription drug and heroin abuse, leaders of the FBI and DEA today unveiled a documentary aimed at educating students and young adults about the dangers of the addiction. “Chasing the Dragon” is a 45-minute documentary film that profiles the...
PRESS RELEASE

DEA And European Authorities Uncover Massive Hizballah Drug And Money Laundering Scheme

WASHINGTON - The United States Drug Enforcement (DEA) today announced significant enforcement activity including arrests targeting Lebanese Hizballah’s External Security Organization Business Affairs (BAC), which is involved in international criminal activities such as drug trafficking and drug proceed money laundering. These proceeds are used to purchase weapons for Hizballah for...
PRESS RELEASE

DEA Statement On The Capture Of Joaquin “Chapo” Guzman-Loera

WASHINGTON - The capture of Joaquin “Chapo” Guzman-Loera is a victory for the rule of law and the Mexican people and government. The arrest is a significant achievement in our shared fight against transnational organized crime, violence, and drug trafficking. It is further evidence of our two countries’ resolve to...
PRESS RELEASE

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

WASHINGTON - The United States Drug Enforcement (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances (CSA) for those who are conducting FDA-approved clinical trials on (CBD), an extract of the marijuana plant. These modifications will streamline the research process regarding CBD’s possible medicinal value and...

Paginación

  • Primera página «
  • Anterior
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Current page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster